Molten Ventures leads a €31 million Series C investment in Deciphex to enhance AI-powered digital pathology and address critical healthcare diagnostic challenges.
Target Information
Deciphex is a pioneering company focused on AI-powered digital pathology solutions. By leveraging advanced technology, the company aims to bridge the gap in pathology diagnostics, addressing the growing demand for high-quality pathology services. The recent €31 million Series C funding round, led by Molten Ventures, reinforces Deciphex's commitment to enhancing healthcare diagnostics globally.
The company’s innovative platform empowers pathologists by improving their workflow efficiency and diagnostic accuracy. With more than 70% of healthcare decisions relying on pathology investigations, Deciphex's AI tools allow pathologists to work up to 40% faster, mitigating the backlog issues commonly faced in healthcare systems worldwide.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview
The healthcare industry, particularly pathology, is facing unprecedented challenges, with a critical shortage of pathologists juxtaposed against rising patient demands. As healthcare systems worldwide grapple wi
Similar Deals
Molten Ventures
invested in
Deciphex
in
in a Other deal
Disclosed details
Transaction Size: $31M